Onward Medical NV ONWD

AMS: ONWD | ISIN: NL0015000HT4 28/10/2025

4,200 EUR (0,00%)

(0,00%) 28/10/2025

Grafiek Onward Medical NV

Grafiek Onward Medical NV

1 dag1d 0,00%
1 week1w -18,29%
1 maand1m -19,08%
3 maanden3m -3,34%
6 maanden6m 1,45%
1 jaar1j -14,29%
5 jaar5j -67,06%

Adviezen van analisten

Koersdoel

12,38 EUR

+194,76%

Consensus

Kopen

Verdeling adviezen

Onward Medical NV in het nieuws

Toon enkel gratis nieuws

28 oktober 2025 · ONWARD Medical Publishes Closing of Bookbuild Offering · Persbericht

24 oktober 2025 · ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase · Persbericht

22 oktober 2025 · ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million · Persbericht

13 oktober 2025 · ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States · Persbericht

8 oktober 2025 · Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 · Persbericht

8 oktober 2025 · Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR · Persbericht

18 september 2025 · Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy · Persbericht

8 september 2025 · ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe · Persbericht

2 september 2025 · ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 · Persbericht

18 augustus 2025 · ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe